TY - JOUR AU - Storer, B. E. PY - 1989 DA - 1989// TI - Design and analysis of phase I clinical trials JO - Biometrics VL - 45 UR - https://doi.org/10.2307/2531693 DO - 10.2307/2531693 ID - Storer1989 ER - TY - JOUR AU - O’Quigley, J. AU - Pepe, M. AU - Fisher, L. PY - 1990 DA - 1990// TI - Continual reassessment method: a practical design for phase 1 clinical trials in cancer JO - Biometrics VL - 46 UR - https://doi.org/10.2307/2531628 DO - 10.2307/2531628 ID - O’Quigley1990 ER - TY - JOUR AU - Goodman, S. N. AU - Zahurak, M. L. AU - Piantadosi, S. PY - 1995 DA - 1995// TI - Some practical improvements in the continual reassessment method for phase I studies JO - Stat Med VL - 14 UR - https://doi.org/10.1002/sim.4780141102 DO - 10.1002/sim.4780141102 ID - Goodman1995 ER - TY - JOUR AU - Thall, P. F. AU - Cook, J. D. PY - 2004 DA - 2004// TI - Dose-finding based on efficacy/toxicity trade-offs JO - Biometrics VL - 60 UR - https://doi.org/10.1111/j.0006-341X.2004.00218.x DO - 10.1111/j.0006-341X.2004.00218.x ID - Thall2004 ER - TY - JOUR AU - Braun, T. M. PY - 2002 DA - 2002// TI - The bivariate continual reassessment method: extending the CRM to phase I trials of two competing outcomes JO - Control Clin Trials VL - 23 UR - https://doi.org/10.1016/S0197-2456(01)00205-7 DO - 10.1016/S0197-2456(01)00205-7 ID - Braun2002 ER - TY - JOUR AU - Zhang, W. AU - Sargent, D. J. AU - Mandrekar, S. PY - 2006 DA - 2006// TI - An adaptive dose-finding design incorporating both toxicity and efficacy JO - Stat Med VL - 25 UR - https://doi.org/10.1002/sim.2325 DO - 10.1002/sim.2325 ID - Zhang2006 ER - TY - BOOK AU - Nelsen, R. PY - 1999 DA - 1999// TI - An Introduction to Copulas PB - Springer CY - New York UR - https://doi.org/10.1007/978-1-4757-3076-0 DO - 10.1007/978-1-4757-3076-0 ID - Nelsen1999 ER - TY - JOUR AU - Iasonos, A. AU - Wilton, A. S. AU - Riedel, E. R. AU - Seshan, V. E. AU - Spriggs, D. R. PY - 2008 DA - 2008// TI - A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in phase I dose-finding studies JO - Clin Trials VL - 5 UR - https://doi.org/10.1177/1740774508096474 DO - 10.1177/1740774508096474 ID - Iasonos2008 ER - TY - JOUR AU - Arnold, B. C. AU - Strauss, D. J. PY - 1991 DA - 1991// TI - Bivariate distributions with conditionals in prescribed exponential families JO - J Roy Stat Soc B VL - 53 ID - Arnold1991 ER - TY - JOUR AU - Murtaugh, P. A. AU - Fisher, L. D. PY - 1990 DA - 1990// TI - Bivariate binary models of efficacy and toxicity in dose-ranging trials JO - Comm Stat Theor Meth VL - 19 UR - https://doi.org/10.1080/03610929008830305 DO - 10.1080/03610929008830305 ID - Murtaugh1990 ER - TY - BOOK PY - 2013 DA - 2013// TI - R: A Language and Environment for Statistical Computing PB - R Foundation for Statistical Computing CY - Vienna ID - ref11 ER - TY - STD TI - Plummer M: rjags: Bayesian Graphical Models using MCMC/2013. [http://CRAN.R-project.org/package=rjags] [R package version 3-10] UR - http://CRAN.R-project.org/package=rjags ID - ref12 ER - TY - JOUR AU - Yin, G. AU - Li, Y. AU - Ji, Y. PY - 2006 DA - 2006// TI - Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios JO - Biometrics VL - 62 UR - https://doi.org/10.1111/j.1541-0420.2006.00534.x DO - 10.1111/j.1541-0420.2006.00534.x ID - Yin2006 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2288/14/51/prepub UR - http://www.biomedcentral.com/1471-2288/14/51/prepub ID - ref14 ER -